| Advancing clinical development for neuronopathic Hunter syndrome through a quantitatively‐driven reverse translation framework RD Latzman, O Campagne, ME Modi, M Karas, CJ Malanga, ... Clinical and Translational Science 17 (4), e13776, 2024 | | 2024 |
| Seizure reduction in TSC2‐mutant mouse model by an mTOR catalytic inhibitor SC Dhamne, ME Modi, A Gray, S Bonazzi, L Craig, E Bainbridge, L Lalani, ... Annals of clinical and translational neurology 10 (10), 1790-1801, 2023 | | 2023 |
| Building a better translational model of neuropathic Gaucher disease ME Modi, N Boukharov, K Tonini, N Paz, MR Alessandrini, K Shah, E Park, ... Molecular Genetics and Metabolism 138 (2), 107226, 2023 | | 2023 |
| GENE TARGET: A framework for evaluating Mendelian neurodevelopmental disorders for gene therapy M Chopra, ME Modi, KA Dies, NL Chamberlin, ED Buttermore, ... Molecular Therapy-Methods & Clinical Development 27, 32-46, 2022 | 6 | 2022 |
| Gasping for Air: Embedded COPD Decision Support Improves Guideline Adherence G Hocum, L Wang, M Modi, SS Sanders | | 2022 |
| Shifted phase of EEG cross-frequency coupling in individuals with Phelan-McDermid syndrome MG Mariscal, E Berry-Kravis, JD Buxbaum, LE Ethridge, R Filip-Dhima, ... Molecular Autism 12 (1), 29, 2021 | 13 | 2021 |
| Phenotypic screen with TSC-deficient neurons reveals heat-shock machinery as a druggable pathway for mTORC1 and reduced cilia A Di Nardo, I Lenoël, KD Winden, A Rühmkorf, ME Modi, L Barrett, ... Cell reports 31 (12), 2020 | 20 | 2020 |
| Tau: a novel entry point for mTOR-based treatments in autism spectrum disorder? ME Modi, M Sahin Neuron 106 (3), 359-361, 2020 | 13 | 2020 |
| Auditory processing of speech and tones in children with tuberous sclerosis complex AM O’Brien, L Bayet, K Riley, CA Nelson, M Sahin, ME Modi Frontiers in Integrative Neuroscience 14, 14, 2020 | 7 | 2020 |
| Translational Electrophysiological Biomarkers in Tuberous Sclerosis Complex, a Genetically Defined Neurodevelopmental Disorder M Modi, A O'Brien, B Tracey, S Dhamne, S Gurnani, A Rotenberg, ... NEUROPSYCHOPHARMACOLOGY 44 (SUPPL 1), 408-409, 2019 | | 2019 |
| A unified circuit for social behavior ME Modi, M Sahin Neurobiology of learning and memory 165, 106920, 2019 | 30 | 2019 |
| A framework for the investigation of rare genetic disorders in neuropsychiatry SJ Sanders, M Sahin, J Hostyk, A Thurm, S Jacquemont, P Avillach, ... Nature medicine 25 (10), 1477-1487, 2019 | 122 | 2019 |
| Electrographic spikes are common in wildtype mice H Purtell, SC Dhamne, S Gurnani, E Bainbridge, ME Modi, SHT Lammers, ... Epilepsy & Behavior 89, 94-98, 2018 | 15 | 2018 |
| The way forward for mechanism‐based therapeutics in genetically defined neurodevelopmental disorders ME Modi, M Sahin Clinical Pharmacology & Therapeutics 104 (4), 603-606, 2018 | 3 | 2018 |
| Methods of improving behavioral therapies LJ Young, ME Modi US Patent 10,058,584, 2018 | 10 | 2018 |
| Hyperactivity and hypermotivation associated with increased striatal mGluR1 signaling in a Shank2 rat model of autism ME Modi, JM Brooks, ER Guilmette, M Beyna, R Graf, D Reim, ... Frontiers in Molecular Neuroscience 11, 107, 2018 | 40 | 2018 |
| mGluR5 modulation of behavioral and epileptic phenotypes in a mouse model of tuberous sclerosis complex E Kelly, SM Schaeffer, SC Dhamne, JO Lipton, L Lindemann, M Honer, ... Neuropsychopharmacology 43 (6), 1457-1465, 2018 | 39 | 2018 |
| Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism SC Dhamne, JL Silverman, CE Super, SHT Lammers, MQ Hameed, ... Molecular autism 8, 1-19, 2017 | 140 | 2017 |
| Translational use of event-related potentials to assess circuit integrity in ASD ME Modi, M Sahin Nature Reviews Neurology 13 (3), 160-170, 2017 | 61 | 2017 |
| mGluR5 modulation of behavioral and epileptic phenotypes in a mouse model of Tuberous Sclerosis Complex Running Title: mGluR5 modulation in Tuberous Sclerosis Complex E Kelly, SM Schaeffer, SC Dhamne, JO Lipton, L Lindemann, M Honer, ... | | 2017 |
